STUART ESSIG - 06 May 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Stuart Essig
Issuer symbol
IDXX
Transactions as of
06 May 2025
Transactions value $
$0
Form type
4
Filing time
08 May 2025, 19:00:53 UTC
Previous filing
03 Apr 2025
Next filing
13 May 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ESSIG STUART Director ONE IDEXX DRIVE, WESTBROOK /s/ Lily J. Lu, Attorney-in-Fact for Stuart Essig 08 May 2025 0001187574

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +262 +13.27% $0.00 2.24K 06 May 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Restricted Stock Unit Options Exercise $0 -262 -100% $0.00 0 06 May 2025 Common Stock 262 Direct F1
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award $0 +600 $0.00 600 07 May 2025 Common Stock 600 $486.61 Direct F2
transaction IDXX Deferred Stock Unit Award $0 +257 $0.00 257 07 May 2025 Common Stock 257 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These restricted stock units vested in one installment on the one year anniversary of the date of grant or on the date of the 2025 annual meeting of shareholders, whichever event was earlier.
F2 Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2026 annual meeting of shareholders, whichever event is earlier.
F3 Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2026 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors.